« Jurassic beaver swims into view | Main | Bad blood »

Drug from GM animal gets thumbs down

Protein made in goats' milk doesn't make it to market.

An application to market a drug made in the milk of genetically modified (GM) goats was turned down this week. The decision means that, despite more than a decade of work using GM animals to produce drugs, no products have yet been approved for use.

Read the story here.

TrackBack

TrackBack URL for this entry:
http://blogs.nature.com/cgi-bin/mt/mt-tb.cgi/268

Comments

I find your report very disturbing that a human antimicrobial peptide (lactoferrin) could find easy approval and widespread use as a food additive. Aren't there concerns that this could lead to evolution of resistant bacteria?

The use of animals to produce human biological products is both lazy science and dangerous for public health. Why risk transmitting prions (BSE -Mad cow disease) with the use of foetal calf serum in human vaccines, or SV40 virus in polio vaccine, through the use of monkey kidney cells? Leaving animals out of the equation means people get a safer product, e.g. synthetic heparin is now available instead of the animal-sourced version, because science and industry decided to put their minds to it.

Post a comment

Comments will be reviewed by staff before being published. You can be as critical or controversial as you like, but please don't get personal or offensive, and do keep it brief. Excessively long entries may be cropped. Remember this is for feedback and discussion - not for publishing papers or press releases.

We strongly encourage you to use your real, full name. Email addresses are required: this is just in case we need to discuss your comment with you privately. They won’t be published.


Please enter the numbers you see below - this helps us to cut down on spam. Note that attempting to post within 30 seconds of hitting ‘preview’ or ‘post’ can cause the system to think you are spamming the site. If you are having trouble with this system, you can instead e-mail a comment to 'inthefield at nature.com'.